Wanbury Limited has announced the appointment of Mr. Prakash Venkatraman as President of the API business. With a stellar career spanning over three decades, Mr. Venkatraman brings a wealth of experience in API operations, P&L management, and business strategy. Mr. Venkatraman holds a Bachelor's degree in
Wanbury Ltd, one of India’s fast growing pharmaceutical company having a presence in API global market and domestic branded formulation today announced the successful completion of the United States Food & Drug Administration (USFDA) inspection at Patalganga site, Maharashtra. The inspection that started from Monday,
Wanbury Ltd., one of India’s fastest growing pharmaceutical company having a presence in API global market and domestic branded Formulation, announced its financial results for the fourth quarter and year ended March 31, 2024. Consolidated Q4 & FY24 Financial Highlights
